| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AUPHAurinia Pharmaceuticals Inc. | 1.96B | 14.87 | 378.37 | 33.97% | 29.28% | 21.28% | 2.25% | 0.21 |
| ARGXargenx SE | 50.33B | 813.24 | 63.63 | 78.6% | 23.34% | 15.14% | 0.01 | |
| INVAInnoviva, Inc. | 1.48B | 19.76 | 54.89 | 15.54% | 32.78% | 12.61% | 12.75% | 0.65 |
| GLPGGalapagos N.V. | 2.24B | 34.03 | 30.38 | 14.99% | -151.94% | -15.16% | 0.00 | |
| PTGXProtagonist Therapeutics, Inc. | 5.3B | 84.75 | 20.04 | 6.24% | 21.94% | 7.11% | 3.45% | 0.02 |
| ALMSAlumis Inc. Common Stock | 2.84B | 24.17 | -2.33 | -11.08% | -63.71% | 0.12 | ||
| PHATPhathom Pharmaceuticals, Inc. | 1.17B | 14.98 | -2.83 | 80.01% | -186.53% | |||
| ORKAOruka Therapeutics, Inc. | 1.57B | 32.50 | -6.51 | -22.44% | 0.00 |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Sales/Revenue | 110K | 284K | 686K | 7.5M |
| Revenue Growth % | - | 1.58% | 1.42% | 9.93% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - |
| Gross Profit | 110K | 284K | 686K | 7.5M |
| Gross Margin % | 1% | 1% | 1% | 1% |
| Gross Profit Growth % | - | 1.58% | 1.42% | 9.93% |
| Operating Expenses | 9.33M | 9.74M | 8.14M | 10.99B |
| OpEx % of Revenue | 84.83% | 34.29% | 11.86% | 1465.69% |
| Selling, General & Admin | 3.95M | 3.64M | 4.49M | 6.27B |
| SG&A % of Revenue | 35.92% | 12.82% | 6.55% | 835.9% |
| Research & Development | 5.38M | 6.1M | 3.64M | 4.72B |
| R&D % of Revenue | 48.91% | 21.47% | 5.31% | 629.78% |
| Other Operating Expenses | 0 | 0 | 0 | 0 |
| Operating Income | -9.22M | -9.45M | -7.45M | -10.99B |
| Operating Margin % | -83.83% | -33.29% | -10.86% | -1464.69% |
| Operating Income Growth % | - | -0.03% | 0.21% | -1473.41% |
| EBITDA | -9.14M | -9.05M | -7.02M | -10.98B |
| EBITDA Margin % | -83.06% | -31.86% | -10.24% | -1464.63% |
| EBITDA Growth % | - | 0.01% | 0.22% | -1562.66% |
| D&A (Non-Cash Add-back) | 84.77K | 405.98K | 425.55K | 448.24K |
| EBIT | -8.87M | -10.43M | -11.1M | -8.95M |
| Net Interest Income | -58.21K | -247.07K | -166.15K | 110.39K |
| Interest Income | 8.76K | 4.82K | 1.58K | 122.55K |
| Interest Expense | 66.97K | 251.89K | 167.73K | 12.16K |
| Other Income/Expense | 281.78K | -1.23M | -3.82M | 10.98B |
| Pretax Income | -8.94M | -10.68M | -11.27M | -8.96M |
| Pretax Margin % | -81.27% | -37.61% | -16.42% | -1.19% |
| Income Tax | 0 | 0 | 17.31K | 9.03K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% |
| Net Income | -8.94M | -10.68M | -11.28M | -8.97M |
| Net Margin % | -81.27% | -37.61% | -16.45% | -1.2% |
| Net Income Growth % | - | -0.19% | -0.06% | 0.21% |
| Net Income (Continuing) | -8.94M | -10.68M | -11.28M | -8.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.33 | -3.98 | -4.20 | -0.36 |
| EPS Growth % | - | -0.19% | -0.06% | 0.92% |
| EPS (Basic) | -3.33 | -3.98 | -7.34 | -0.36 |
| Diluted Shares Outstanding | 60.49K | 60.49K | 34.51K | 567.57K |
| Basic Shares Outstanding | 60.49K | 60.49K | 34.51K | 567.57K |
| Dividend Payout Ratio | - | - | - | - |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Total Current Assets | 8.49M | 4.14M | 2.54M | 5.23M |
| Cash & Short-Term Investments | 8.04M | 3.49M | 1.8M | 4.55M |
| Cash Only | 8.04M | 3.49M | 1.8M | 4.55M |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 334.18K | 266.21K | 223.47K | 101.9K |
| Days Sales Outstanding | 1.11K | 342.13 | 118.9 | 4.96 |
| Inventory | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - |
| Other Current Assets | 0 | 216.89K | 67.86K | 4.11K |
| Total Non-Current Assets | 1.71M | 3.03M | 2.58M | 2.13M |
| Property, Plant & Equipment | 946.68K | 1.96M | 1.58M | 1.21M |
| Fixed Asset Turnover | 0.12x | 0.14x | 0.43x | 6.22x |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 97.69K | 219.57K | 210.88K | 246.42K |
| Long-Term Investments | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 668.23K | 848.34K | 789.99K | 678.22K |
| Total Assets | 10.2M | 7.17M | 5.12M | 7.36M |
| Asset Turnover | 0.01x | 0.04x | 0.13x | 1.02x |
| Asset Growth % | - | -0.3% | -0.29% | 0.44% |
| Total Current Liabilities | 1.21M | 2.22M | 1.6M | 1.38M |
| Accounts Payable | 717.8K | 784.69K | 897.27K | 490.25K |
| Days Payables Outstanding | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 15K | 156K | 0 | 0 |
| Other Current Liabilities | 43.47K | 27.08K | 145.04K | 32.97K |
| Current Ratio | 7.02x | 1.86x | 1.58x | 3.80x |
| Quick Ratio | 7.02x | 1.86x | 1.58x | 3.80x |
| Cash Conversion Cycle | - | - | - | - |
| Total Non-Current Liabilities | 34.76M | 41.21M | 599.14K | 284.65K |
| Long-Term Debt | 992.02K | 6.6M | 0 | 0 |
| Capital Lease Obligations | 0 | 840.9K | 563.69K | 284.27K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 33.77M | 33.76M | 35.45K | 381 |
| Total Liabilities | 35.97M | 43.43M | 2.2M | 1.66M |
| Total Debt | 992.02K | 7.73M | 885.95K | 555.51K |
| Net Debt | -7.05M | 4.24M | -910.04K | -4M |
| Debt / Equity | - | - | 0.30x | 0.10x |
| Debt / EBITDA | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - |
| Interest Coverage | -137.70x | -37.53x | -44.42x | -903383.22x |
| Total Equity | -25.77M | -36.26M | 2.91M | 5.7M |
| Equity Growth % | - | -0.41% | 1.08% | 0.96% |
| Book Value per Share | -425.93 | -599.41 | 84.40 | 10.04 |
| Total Shareholders' Equity | -25.77M | -36.26M | 2.91M | 5.7M |
| Common Stock | 104 | 104 | 1.21K | 763 |
| Retained Earnings | -26.63M | -37.31M | -48.6M | -57.57M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Cash from Operations | -8.07M | -8.35M | -7.36M | -10.18M |
| Operating CF Margin % | -73.34% | -29.4% | -10.73% | -1.36% |
| Operating CF Growth % | - | -0.03% | 0.12% | -0.38% |
| Net Income | -8.94M | -10.68M | -11.28M | -8.97M |
| Depreciation & Amortization | 84.77K | 405.98K | 425.55K | 448.24K |
| Stock-Based Compensation | 306.06K | 184.47K | 151.5K | 245.05K |
| Deferred Taxes | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -164.86K | 1.43M | 4.1M | -1.47M |
| Working Capital Changes | 646.35K | 310.76K | -753.43K | -441.72K |
| Change in Receivables | 194.17K | 66.67K | 42.73K | 133.15K |
| Change in Inventory | 0 | 0 | 0 | 0 |
| Change in Payables | 282.98K | 420.75K | -68.68K | -140.53K |
| Cash from Investing | -652.27K | -336.76K | -318.26K | -379.25K |
| Capital Expenditures | -446.14K | -33.1K | -26.54K | -8.57K |
| CapEx % of Revenue | 4.06% | 0.12% | 0.04% | 0% |
| Acquisitions | - | - | - | - |
| Investments | - | - | - | - |
| Other Investing | -206.14K | -303.66K | -291.71K | -370.68K |
| Cash from Financing | 992.86K | 4.13M | 5.98M | 13.32M |
| Debt Issued (Net) | - | - | - | - |
| Equity Issued (Net) | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - |
| Other Financing | 8.47K | -215.38K | 0 | -18.38K |
| Net Change in Cash | - | - | - | - |
| Free Cash Flow | -8.72M | -8.69M | -7.68M | -10.56M |
| FCF Margin % | -79.27% | -30.6% | -11.2% | -1.41% |
| FCF Growth % | - | 0% | 0.12% | -0.38% |
| FCF per Share | -144.14 | -143.66 | -222.53 | -18.61 |
| FCF Conversion (FCF/Net Income) | 0.90x | 0.78x | 0.65x | 1.14x |
| Interest Paid | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 |
| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -387.34% | -208.27% |
| Return on Invested Capital (ROIC) | - | - | -278.96% | -445079.83% |
| Gross Margin | 100% | 100% | 100% | 100% |
| Net Margin | -8126.98% | -3760.69% | -1644.87% | -119.57% |
| Debt / Equity | - | - | 0.30x | 0.10x |
| Interest Coverage | -137.70x | -37.53x | -44.42x | -903383.22x |
| FCF Conversion | 0.90x | 0.78x | 0.65x | 1.14x |
| Revenue Growth | - | 158.18% | 141.55% | 993.29% |
Azitra, Inc. (AZTR) reported $7.5M in revenue for fiscal year 2024. This represents a 6718% increase from $0.1M in 2021.
Azitra, Inc. (AZTR) grew revenue by 993.3% over the past year. This is strong growth.
Azitra, Inc. (AZTR) reported a net loss of $11.1M for fiscal year 2024.
Azitra, Inc. (AZTR) has a return on equity (ROE) of -208.3%. Negative ROE indicates the company is unprofitable.
Azitra, Inc. (AZTR) had negative free cash flow of $11.1M in fiscal year 2024, likely due to heavy capital investments.